CD5 and Alzheimer disease: When considering circulating cytokines as the exposures, our analysis showed that IL-13, IL-18R1, TNFSF14 and TRANCE were potential upstream causal contributors to the development of AD, while CXCL11, IL-33, TNF-β and CD5 appeared to be associated with the decreased risk of AD.